Journal
/
/
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson’s Disease
JoVE 杂志
医学
This content is Free Access.
JoVE 杂志 医学
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson’s Disease
DOI:

16:57 min

February 14, 2012

, ,

Chapters

  • 00:05Title
  • 02:02Tissue Preparation
  • 03:40Matrix Application
  • 05:24MALDI MS Data Acquisition, Processing, and Evaluation
  • 12:29Neuropeptide Validation
  • 14:18Representative MALDI-MS Results
  • 15:55Conclusion

Summary

自动翻译

Dopamine replacement pharmacotherapy using L-DOPA is the most commonly used symptomatic treatment of Parkinson’s disease, but is accompanied by side effects including involuntary abnormal movements, termed dyskinesia 1. Here, a protocol for MALDI imaging mass spectrometry is presented that detects changes in rat brain neuropeptide levels related to dyskinesia.

Related Videos

Read Article